Natus to Participate in the 24th Annual Needham Virtual Growth Conference
07 Janvier 2022 - 10:10PM
Natus Medical Incorporated (NASDAQ: NTUS), (the
“Company” or “Natus”), a leading provider of medical device
solutions focused on the diagnosis and treatment of central nervous
and sensory system disorders for patients of all ages, today
announced that Thomas J. Sullivan, President and Chief Executive
Officer, and Drew Davies, Executive Vice President and Chief
Financial Officer, will be presenting at the 24th Annual Needham
Virtual Growth Conference from 2:00 PM to 2:40 PM ET on Friday,
January 14th.
In addition, Mr. Sullivan and Mr. Davies will
also host one-on-one meetings during the day with institutional
investors. Investors interested in scheduling a meeting should
contact a Needham representative. Investors may listen to a live
webcast online via the “Investors” section of the Company’s web
site at http://investor.natus.com. The recorded webcast will be
accessible online for at least 30 days.
About Natus Medical
Incorporated
Natus offers medical equipment, software,
supplies and services for the diagnosis, monitoring and treatment
of impairments and disorders affecting newborns, the brain, nerves,
muscles, balance, mobility and hearing. Natus products are used in
hospitals, clinics and laboratories worldwide.
Additional information about Natus Medical can
be found at www.natus.com.
COMPANY CONTACT: Natus Medical Incorporated Drew
DaviesExecutive Vice President and Chief Financial Officer(925)
223-6700InvestorRelations@Natus.com
Natus Medical (NASDAQ:NTUS)
Graphique Historique de l'Action
De Août 2024 à Sept 2024
Natus Medical (NASDAQ:NTUS)
Graphique Historique de l'Action
De Sept 2023 à Sept 2024
Real-Time news about Natus Medical Inc (NASDAQ): 0 recent articles
Plus d'articles sur